Here’s Why the Media DOESN’T Stand Up to Big Pharma Greed as Drug Prices Skyrocket in US
In an Op-Ed published in The LA Times, Vermont Senator and former Democratic presidential candidate Bernie Sanders, penned:
“One out of five Americans age 19 to 64 cannot afford their prescriptions. Hundreds of thousands of seniors cut their pills in half to stretch one month’s prescription into two. Meanwhile, the five largest drug companies made more than $50 billion in profits last year.
“The top 10 CEOs in the industry received a total of more than $327 million in compensation. They [Big Pharma] currently have 1,266 lobbyists on their payrolls in Washington, D.C., and 118 fighting for their priorities in Sacramento. They’ve made hundreds of millions in campaign contributions to politicians.”
Though rising prescription drug prices is a major health crisis nationwide, corporate media largely ignored the issue important to millions of Americans.
Latest News from Ring Of Fire Radio/Drug Safety News
- How the J & J Bankruptcy Could Affect Talc Cancer Lawsuitsby Levin Papantio Law October 23, 2021
Plaintiffs in talc cancer lawsuits against Johnson & Johnson have had a white-knuckle time of it after hearing the company’s plans to file bankruptcy. If […]
- Symptoms, Diagnosis, and Treatment of BIA-ALCLby Levin Papantio Law October 22, 2021
According to the U.S. Food and Drug Administration (FDA), by January of 2020, the government agency had received 733 medical device reports (MDRs) of breast […]
- Superior Court Judge Sets Dates for First U.S. Zantac Trialsby Levin Papantio Law October 6, 2021
Superior Court Judge Evelio Grillo for the County of Alameda, who oversees the California Ranitidine Product Cases Judicial Council Coordinated Proceedings […]
- Panel Considers Consolidating CPAP Lawsuitsby Levin Papantio Law October 6, 2021
As of September 28, 2021, a total of 93 class actions had been filed against Continuous Positive Air Pressure (CPAP) maker Philips Respironics. The Judicial […]
- Lawsuits Filed for CION Investment Corp. (CIC) Investment Lossesby Levin Papantio Law October 6, 2021
The Levin Papantonio Rafferty law firm currently represents customers in claims to recover their investment losses in CION Investment Corp. On Tuesday, October […]
- FDA Requires New Warnings for Xeljanz and Other Arthritis Medicines Due to Heart Risksby Levin Papantio Law September 18, 2021
The U.S. Food and Drug Administration (FDA) issued a Drug Safety Communication (DSC) regarding the arthritis and ulcerative colitis drug Xeljanz (and Xeljanz […]
- Claims Filed Regarding Former Sarasota Financial Advisor Marc Korsch for Sale of Allegedly Speculative and High-Risk REITs and Illiquid Investments to Retireesby Levin Papantio Law September 11, 2021
The Levin Papantonio Rafferty law firm announced today that it has filed claims on behalf of retiree investors who are former clients of Sarasota-area […]
- MJ Capital Funding Accused of Ponzi Scheme – Investors May Have Right to Recover Lossesby Levin Papantio Law August 25, 2021
The Securities and Exchange Commission has filed a complaint against MJ Capital Funding, LLC, MJ Taxes and More Inc. and Johanna M. Garcia, the owner of MJ […]
- Moody National REIT II – Investors May Have Right to Recover Lossesby Levin Papantio Law August 13, 2021
Investors in Moody National REIT II may have suffered devastating losses. Moody announced that its Board had decided to postpone the valuation of Moody […]
- Philips Recalls V60 Plus Ventilators Equipped With High Flow Therapyby Levin Papantio Law August 13, 2021
The U.S. Food and Drug Administration (FDA) issued notice that Philips Respironics recalled its V60 Plus Ventilators Equipped with High Flow Therapy (software […]
